HIKAL
Back to All Ratios
|
HIKAL Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/CE(x) | 2.03 | 2.21 | 3.21 | 1.52 | 0.99 |
What is the latest EV/CE ratio of HIKAL ?
Year | EV/CE |
---|---|
Mar2024 | 2.03 |
Mar2023 | 2.21 |
Mar2022 | 3.21 |
Mar2021 | 1.52 |
Mar2020 | 0.99 |
How is EV/CE of HIKAL Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 2.03 | -8.14 | |
Mar2023 | 2.21 | -31.15 | |
Mar2022 | 3.21 | 111.18 | |
Mar2021 | 1.52 | 53.54 | |
Mar2020 | 0.99 | - |
Other Financial Ratios of HIKAL
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹4,285.9 Cr | -0.4% | -13.8% | 21.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,744.0 Cr | -4.2% | -7.7% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,209.0 Cr | -0.6% | -5.6% | 57.5% | Stock Analytics | |
CIPLA | ₹117,762.0 Cr | 3.3% | -4.8% | 6.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,705.3 Cr | -2.4% | -12.8% | 1.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,929.3 Cr | -0.3% | -2.1% | 24.5% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | -0.4% |
-13.8% |
21.5% |
SENSEX | 0.3% |
-1.8% |
8.6% |
You may also like the below Video Courses